{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:02:46Z","timestamp":1788825766533,"version":"build-2803163510"},"reference-count":20,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2010,9,14]],"date-time":"2010-09-14T00:00:00Z","timestamp":1284422400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2011,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Worldwide clinical trials and post\u2010marketing surveillance data have demonstrated an increased incidence of tuberculosis (TB) disease associated with antitumour necrosis factor (anti\u2010TNF) agents. The majority of these cases are presumed to result from a reactivation of latent disease, while the rate of new infections is unknown. A study was performed to evaluate the incidence of latent tuberculosis infection (LTBI) in psoriatic patients screened for biological therapy in a high\u2010incidence area, such as Madrid, Spain.<\/jats:p><jats:p><jats:bold>Patients and methods\u2002<\/jats:bold> One hundred and forty\u2010four patients with moderate\u2010to\u2010severe psoriasis treated with anti\u2010TNF agents were recruited. All of them were screened for active TB or LTBI before therapy. The screening included a detailed medical study, physical examination, chest X\u2010ray, tuberculin skin test (TST) with purified protein derivative and re\u2010TST.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> A total of 42 (29%) patients were diagnosed with LTBI based on a positive TST or re\u2010TST, and\/or signs of past TB in the chest X\u2010ray. All of them received chemoprophylaxis with isoniazide. One patient developed a primary active lymphnode TB.<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold> This is the first study to underscore the incidence of LTBI in patients with psoriasis treated with anti\u2010TNF therapy in the Spanish population. We support that the use of TST is still reliable and an effective diagnostic method for the detection of LTBI in anti\u2010TNF therapy.<\/jats:p>","DOI":"10.1111\/j.1468-3083.2010.03836.x","type":"journal-article","created":{"date-parts":[[2010,9,14]],"date-time":"2010-09-14T18:01:41Z","timestamp":1284487301000},"page":"730-733","source":"Crossref","is-referenced-by-count":34,"title":["Incidence of tuberculosis infection in psoriatic patients on anti\u2010TNF therapy: report of a case series with 144 patients"],"prefix":"10.1111","volume":"25","author":[{"given":"AI","family":"S\u00e1nchez\u2010Moya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Dauden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,9,14]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.05.033"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0001-7310(06)73342-7"},{"key":"e_1_2_6_4_2","first-page":"1261","article-title":"Tumor necrosis factor and its blockade in granulomatous infections: differential modes of action of infliximab and etanercept?","volume":"38","author":"Ehlers S","year":"2004","journal-title":"Clin Infect Dis"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.21043"},{"key":"e_1_2_6_6_2","first-page":"1","volume-title":"Global Tuberculosis Control. Surveillance, Planning, Financing","author":"World Health Organization","year":"2005"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1157\/13126836"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0001-7310(09)71257-8"},{"key":"e_1_2_6_9_2","first-page":"1192","article-title":"False\u2010positive tuberculin skin test: what is the absolute effect of BCG and non\u2010tuberculous mycobacteria?","volume":"10","author":"Farhat M","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09331.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09505.x"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1159\/000222431"},{"key":"e_1_2_6_13_2","first-page":"899","article-title":"Tuberculosis y micobacteriosis","volume":"51","author":"Vidal R","year":"2006","journal-title":"Med Respir"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0962-8479(96)90076-3"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.161.14.1760"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1410.080233"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1586\/14737159.6.3.413"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-5-200703060-00006"},{"key":"e_1_2_6_19_2","first-page":"743","article-title":"Etanercept therapy in patients with a positive tuberculin skin test","volume":"25","author":"Manadan AM","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.22768"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08891.x"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-3083.2010.03836.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-3083.2010.03836.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T06:36:41Z","timestamp":1697351801000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-3083.2010.03836.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,14]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["10.1111\/j.1468-3083.2010.03836.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-3083.2010.03836.x","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,14]]}}}